Details of Drug

Details of Drug

 Drug General Information (ID: D1657)
  Drug Name
Trovafloxacin
  Drug Type Small molecule
  Drug Synonymous
TVFX; Trovan; Fluorinated quinolone; Trovafloxacin [INN]; CP 99219; CP99219; CP 99,219; CP-99219;Trovafloxacin (INN); Trovan (TN); Trovan (oral); Turvel (TN); CP-99,219; (1alpha,5alpha,6alpha)-7-(6-Amino-3-azabicyclo[3.1.0]hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 7-((1R,5S)-6-Amino-3-aza-bicyclo[3.1.0]hex-3-yl)-1-(2,4-difluoro-phenyl)-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid; 7-[(1R,5S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid; 7-[(1R,5S,6s)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 7-[(1r,5s)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
    Click to Show/Hide
  Disease Class 1A00-1C4Z: Bacterial infection
  Therapeutic Class Antiinfective Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C20H15F3N4O3
  InChI 1S/C20H15F3N4O3/c21-8-1-2-15(13(22)3-8)27-7-12(20(29)30)17(28)9-4-14(23)19(25-18(9)27)26-5-10-11(6-26)16(10)24/h1-4,7,10-11,16H,5-6,24H2,(H,29,30)/t10-,11+,16?
  InChIKey WVPSKSLAZQPAKQ-SOSAQKQKSA-N
  Canonical SMILES C1C2C(C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F
  External Link
Pubchem ID 62959
CAS Number 147059-72-1
CHEBI ID 9763
TTD ID D03WPA

Drug-Drug Interaction Network
  Sunburst Graph
AM001  Affected gastrointestinal absorption
AM003  Affected organization distribution
AM005  Affected excretion pathways
AM006  Pharmacodynamic additive effects
AM007  Pharmacodynamic antagonistic effects
BM002  Altered intestinal flora
BM003  Complex formation
BM006  Altered intestinal mucosa
BM014  Interference of cell/tissue uptake
BM028  Competitive inhibition of renal tubular secretion
BM029  Altered urine pH
BM038  Additive CNS depression effects
BM039  Additive CNS stimulant effects
BM050  Increased risk of bleeding
BM055  Increased risk of hepatotoxicity
BM064  Increased risk of hypoglycemia
BM069  Increased risk of lowers seizure threshold
BM075  Increased risk of photosensitivity reactions
BM080  Increased risk of tendinitis/tendon rupture
BM086  Antagonize the effect of antidiabetic agents
BM089  Antagonize the effect of antihypertensive agents
BM100  Antagonize the effect of vaccine/toxoid
BM107  Attenuated pharmacological effects (Unspecific)
BM109  Increased risk of other adverse reactions (Unspecific)
  Relation Graph
 Full list of drugs interacting with Trovafloxacin
      Affected gastrointestinal absorption
   Altered intestinal flora Drug Num:  2
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1094
 
Mycophenolate mofetil
 
C23H31NO7
 
5281078 
Moderate    Inter Info   
[146], [147]
D1095
 
Mycophenolic acid
 
C17H20O6
 
446541 
Moderate    Inter Info   
[146], [147]
   Complex formation Drug Num:  37
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0235
 
Calcium acetate
 
C4H6CaO4
 
6116 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D0975
 
Magnesium sulfate
 
MgO4S
 
24083 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D1462
 
Sevelamer
 
C6H12ClNO
 
3085017 
Moderate    Inter Info   
[117]
D1511
 
Sucralfate
 
C12H54Al9O55S8
 
121494085 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D0049
 
Aluminum hydroxide
 
AlH3O3
 
10176082 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D0125
 
Attapulgite
 
Al2H29Mg2O15Si4-
 
56842194 
Moderate    Inter Info   
[63], [64], [75]
D0236
 
Calcium carbonate
 
CCaO3
 
10112 
Moderate    Inter Info   
[63], [64], [75]
D0238
 
Calcium citrate
 
C12H10Ca3O14
 
13136 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D0239
 
Calcium glubionate anhydrous
 
C18H32CaO19
 
64776 
Moderate    Inter Info   
[63], [64], [75]
D0241
 
Calcium gluconate
 
C12H22CaO14
 
9290 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D0242
 
Calcium glycerophosphate
 
C3H7CaO6P
 
120096 
Moderate    Inter Info   
[63], [64], [75]
D0243
 
Calcium lactate
 
C6H10CaO6
 
13144 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D0244
 
Calcium Phosphate
 
Ca3O8P2
 
24456 
Moderate    Inter Info   
[63], [64], [75]
D0332
 
Chromium picolinate
 
C18H12CrN3O6
 
151932 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D0390
 
Copper gluconate
 
C12H22CuO14
 
10692 
Moderate    Inter Info   
[63], [64], [75]
D0483
 
Didanosine
 
C10H12N4O3
 
135398739 
Moderate    Inter Info   
[125], [126], [127], [70], [128], [75], [129]
D0619
 
Ethinylestradiol
 
C20H24O2
 
5991 
Moderate    Inter Info   
[130], [131], [132]
D0649
 
Ferrous fumarate
 
C4H2FeO4
 
6433164 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D0650
 
Ferrous gluconate
 
C12H22FeO14
 
23616740 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D0651
 
Ferrous sulfate anhydrous
 
FeO4S
 
24393 
Moderate    Inter Info   
[63], [64], [75]
D0847
 
Iron
 
Fe
 
23925 
Moderate    Inter Info   
[63], [64], [75]
D0849
 
Iron protein succinylate
 
NA
 
NA
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D0877
 
Kaolin
 
Al2H4O9Si2
 
56841936 
Moderate    Inter Info   
[63], [64], [75]
D0893
 
Lanthanum carbonate
 
C3La2O9
 
168924 
Moderate    Inter Info   
[23], [48], [10], [143], [144], [145]
D0967
 
Magaldrate
 
AlHMgO5S+2
 
3086011 
Moderate    Inter Info   
[63], [64], [75]
D0968
 
Magnesium carbonate
 
CMgO3
 
11029 
Moderate    Inter Info   
[63], [64], [75]
D0969
 
Magnesium chloride
 
Cl2H12MgO6
 
643991 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D0970
 
Magnesium citrate
 
C12H10Mg3O14
 
6099959 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D0972
 
Magnesium glycinate
 
C4H8MgN2O4
 
84645 
Moderate    Inter Info   
[63], [64], [75]
D0973
 
Magnesium hydroxide
 
H2MgO2
 
14791 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D0974
 
Magnesium oxide
 
MgO
 
14792 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D1011
 
Mestranol
 
C21H26O2
 
6291 
Moderate    Inter Info   
[130], [131], [132]
D1456
 
Selenium
 
Se
 
6326970 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D1566
 
Tetraferric tricitrate decahydrate
 
C18H32Fe4O31
 
90478690 
Moderate    Inter Info   
[63], [64], [75]
D1722
 
Zinc acetate
 
C4H6O4Zn
 
11192 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D1724
 
Zinc gluconate
 
C12H22O14Zn
 
443445 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D1725
 
Zinc sulfate
 
O4SZn
 
24424 
Moderate    Inter Info   
[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [7], [67], [8], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
   Altered intestinal mucosa Drug Num:  55
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0030
 
Aldesleukin
 
NA
 
NA
Minor    Inter Info   
[102]
D0048
 
Altretamine
 
C9H18N6
 
2123 
Minor    Inter Info   
[102]
D0190
 
Bleomycin
 
C55H84N17O21S3+
 
5360373 
Minor    Inter Info   
[102]
D0264
 
Carmustine
 
C5H9Cl2N3O2
 
2578 
Minor    Inter Info   
[102]
D0312
 
Chlorambucil
 
C14H19Cl2NO2
 
2708 
Minor    Inter Info   
[102]
D0344
 
Cisplatin
 
Cl2H6N2Pt
 
5702198 
Minor    Inter Info   
[102]
D0400
 
Cyclophosphamide
 
C7H15Cl2N2O2P
 
2907 
Minor    Inter Info   
[102]
D0442
 
Denileukin diftitox
 
NA
 
NA
Minor    Inter Info   
[102]
D0584
 
Epirubicin
 
C27H29NO11
 
41867 
Minor    Inter Info   
[102]
D0666
 
Floxuridine
 
C9H11FN2O5
 
5790 
Minor    Inter Info   
[102]
D0675
 
Fluorouracil
 
C4H3FN2O2
 
3385 
Minor    Inter Info   
[102]
D0714
 
Gemcitabine
 
C9H11F2N3O4
 
60750 
Minor    Inter Info   
[102]
D0717
 
Gemtuzumab ozogamicin
 
NA
 
NA
Minor    Inter Info   
[102]
D1077
 
Mitomycin
 
C15H18N4O5
 
5746 
Minor    Inter Info   
[102]
D1250
 
Pentostatin
 
C11H16N4O4
 
439693 
Minor    Inter Info   
[102]
D1508
 
Streptozocin
 
C8H15N3O7
 
29327 
Minor    Inter Info   
[102]
D1551
 
Teniposide
 
C32H32O13S
 
452548 
Minor    Inter Info   
[102]
D1589
 
Tioguanine
 
C5H5N5S
 
2723601 
Minor    Inter Info   
[102]
D0223
 
Busulfan
 
C6H14O6S2
 
2478 
Minor    Inter Info   
[102]
D0249
 
Capecitabine
 
C15H22FN3O6
 
60953 
Minor    Inter Info   
[102]
D0260
 
Carboplatin
 
C6H12N2O4Pt
 
426756 
Minor    Inter Info   
[102]
D0404
 
Cytarabine
 
C9H13N3O5
 
6253 
Minor    Inter Info   
[102]
D0407
 
Dacarbazine
 
C6H10N6O
 
135398738 
Minor    Inter Info   
[102]
D0410
 
Dactinomycin
 
C62H86N12O16
 
457193 
Minor    Inter Info   
[102]
D0429
 
Daunorubicin
 
C27H29NO10
 
30323 
Minor    Inter Info   
[102]
D0430
 
Daunorubicin (liposomal)
 
C27H29NO10
 
30323 
Minor    Inter Info   
[102]
D0511
 
Docetaxel
 
C43H53NO14
 
148124 
Minor    Inter Info   
[102]
D0528
 
Doxorubicin
 
C27H29NO11
 
31703 
Minor    Inter Info   
[102]
D0529
 
Doxorubicin (liposomal)
 
C27H29NO11
 
31703 
Minor    Inter Info   
[102]
D0627
 
Etoposide
 
C29H32O13
 
36462 
Minor    Inter Info   
[102]
D0669
 
Fludarabine
 
C10H12FN5O4
 
657237 
Minor    Inter Info   
[102]
D0780
 
Hydroxyurea
 
CH4N2O2
 
3657 
Minor    Inter Info   
[102]
D0788
 
Idarubicin
 
C26H27NO9
 
42890 
Minor    Inter Info   
[102]
D0790
 
Ifosfamide
 
C7H15Cl2N2O2P
 
3690 
Minor    Inter Info   
[102]
D0845
 
Irinotecan
 
C33H38N4O6
 
60838 
Minor    Inter Info   
[102]
D0945
 
Lomustine
 
C9H16ClN3O2
 
3950 
Minor    Inter Info   
[102]
D0962
 
Lurbinectedin
 
C41H44N4O10S
 
57327016 
Minor    Inter Info   
[102]
D0986
 
Mechlorethamine
 
C5H11Cl2N
 
4033 
Minor    Inter Info   
[102]
D0996
 
Melphalan
 
C13H18Cl2N2O2
 
460612 
Minor    Inter Info   
[102]
D0997
 
Melphalan flufenamide
 
C24H30Cl2FN3O3
 
9935639 
Minor    Inter Info   
[102]
D1007
 
Mercaptopurine
 
C5H4N4S
 
667490 
Minor    Inter Info   
[102]
D1079
 
Mitoxantrone
 
C22H28N4O6
 
4212 
Minor    Inter Info   
[102]
D1212
 
Paclitaxel
 
C47H51NO14
 
36314 
Minor    Inter Info   
[102]
D1213
 
Paclitaxel (protein-bound)
 
C47H51NO14
 
36314 
Minor    Inter Info   
[102]
D1305
 
Plicamycin
 
C52H76O24
 
163659 
Minor    Inter Info   
[102]
D1345
 
Procarbazine
 
C12H19N3O
 
4915 
Minor    Inter Info   
[102]
D1548
 
Temozolomide
 
C6H6N6O2
 
5394 
Minor    Inter Info   
[102]
D1575
 
Thiotepa
 
C6H12N3PS
 
5453 
Minor    Inter Info   
[102]
D1610
 
Topotecan
 
C23H23N3O5
 
60700 
Minor    Inter Info   
[102]
D1626
 
Tretinoin
 
C20H28O2
 
444795 
Minor    Inter Info   
[102]
D1667
 
Uracil mustard
 
C8H11Cl2N3O2
 
6194 
Minor    Inter Info   
[102]
D1697
 
Vinblastine
 
C46H58N4O9
 
13342 
Minor    Inter Info   
[102]
D1698
 
Vincristine
 
C46H56N4O10
 
5978 
Minor    Inter Info   
[102]
D1699
 
Vincristine (liposome)
 
C46H56N4O10
 
5978 
Minor    Inter Info   
[102]
D1700
 
Vinorelbine
 
C45H54N4O8
 
5311497 
Minor    Inter Info   
[102]
      Affected organization distribution
   Interference of cell/tissue uptake Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1817
 
Indium In-111 oxyquinoline
 
C27H18InN3O3
 
16685037 
Moderate    Inter Info   
[142]
      Affected excretion pathways
   Competitive inhibition of renal tubular secretion Drug Num:  2
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1025
 
Methotrexate
 
C20H22N8O5
 
126941 
Moderate    Inter Info   
[102], [103], [104]
D1341
 
Probenecid
 
C13H19NO4S
 
4911 
Minor    Inter Info   
[67], [155], [156]
   Altered urine pH Drug Num:  3
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1760
 
Citric acid
 
C6H8O7
 
311 
Moderate    Inter Info   
[105], [2]
D1319
 
Potassium citrate
 
C6H5K3O7
 
13344 
Moderate    Inter Info   
[105], [2]
D1483
 
Sodium citrate
 
C6H5Na3O7
 
6224 
Moderate    Inter Info   
[105], [2]
      Pharmacodynamic additive effects
   Additive CNS depression effects Drug Num:  9
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0298
 
Celecoxib
 
C17H14F3N3O2S
 
2662 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D0645
 
Fenoprofen
 
C15H14O3
 
3342 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D0800
 
Indomethacin
 
C19H16ClNO4
 
3715 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D0882
 
Ketorolac
 
C15H13NO3
 
3826 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D0489
 
Diflunisal
 
C13H8F2O3
 
3059 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D0624
 
Etodolac
 
C17H21NO3
 
3308 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D0680
 
Flurbiprofen
 
C15H13FO2
 
3394 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D0786
 
Ibuprofen
 
C13H18O2
 
3672 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D0881
 
Ketoprofen
 
C16H14O3
 
3825 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
   Additive CNS stimulant effects Drug Num:  17
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1300
 
Piroxicam
 
C15H13N3O4S
 
54676228 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D1421
 
Rofecoxib
 
C17H14O4S
 
5090 
Moderate    Inter Info   
[82], [6], [67]
D1520
 
Sulindac
 
C20H17FO3S
 
1548887 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D1606
 
Tolmetin
 
C15H15NO3
 
5509 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D0017
 
Acetylsalicylic acid
 
C9H8O4
 
2244 
Moderate    Inter Info   
[82], [6], [67]
D0210
 
Bromfenac
 
C15H12BrNO3
 
60726 
Moderate    Inter Info   
[82], [6], [67]
D0331
 
Choline salicylate
 
C12H19NO4
 
54686350 
Moderate    Inter Info   
[82], [6], [67]
D0988
 
Meclofenamic acid
 
C14H11Cl2NO2
 
4037 
Moderate    Inter Info   
[6], [67], [82]
D0991
 
Mefenamic acid
 
C15H15NO2
 
4044 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D0995
 
Meloxicam
 
C14H13N3O4S2
 
54677470 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D1109
 
Naproxen
 
C14H14O3
 
156391 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D1196
 
Oxaprozin
 
C18H15NO3
 
4614 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D1272
 
Phenyl salicylate
 
C13H10O3
 
8361 
Moderate    Inter Info   
[82], [6], [67]
D1274
 
Phenylbutazone
 
C19H20N2O2
 
4781 
Moderate    Inter Info   
[82], [6], [67]
D1439
 
Salicylic acid (sodium)
 
C7H6O3
 
338 
Moderate    Inter Info   
[82], [6], [67]
D1442
 
Salsalate
 
C14H10O5
 
5161 
Moderate    Inter Info   
[67], [68], [2], [6], [80], [81], [82], [83], [84], [85], [86], [87], [88], [8]
D1674
 
Valdecoxib
 
C16H14N2O3S
 
119607 
Moderate    Inter Info   
[82], [6], [67]
   Increased risk of bleeding Drug Num:  3
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0481
 
Dicoumarol
 
C19H12O6
 
54676038 
Major    Inter Info   
[12], [13], [14]
D0087
 
Anisindione
 
C16H12O3
 
2197 
Major    Inter Info   
[12], [13], [14]
D1711
 
Warfarin
 
C19H16O4
 
54678486 
Major    Inter Info   
[12], [13], [14]
   Increased risk of hepatotoxicity Drug Num:  21
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0900
 
Leflunomide
 
C12H9F3N2O2
 
3899 
Major    Inter Info   
[23], [39], [40]
D0944
 
Lomitapide
 
C39H37F6N3O2
 
9853053 
Major    Inter Info   
[41]
D1073
 
Mipomersen
 
C230H324N67O122P19S19
 
118984467 
Major    Inter Info   
[42]
D1258
 
Pexidartinib
 
C20H15ClF3N5
 
25151352 
Major    Inter Info   
[43]
D1556
 
Teriflunomide
 
C12H9F3N2O2
 
54684141 
Major    Inter Info   
[23], [39], [40]
D0114
 
Asparaginase Escherichia coli
 
NA
 
NA
Moderate    Inter Info   
[47], [48], [49]
D0357
 
Clofarabine
 
C10H11ClFN5O3
 
119182 
Moderate    Inter Info   
[89]
D0554
 
Efavirenz
 
C14H9ClF3NO2
 
64139 
Moderate    Inter Info   
[90], [91]
D0826
 
Interferon beta-1a
 
NA
 
NA
Moderate    Inter Info   
[92], [93], [94], [95]
D0827
 
Interferon beta-1b
 
NA
 
NA
Moderate    Inter Info   
[92], [93], [94], [95]
D1234
 
Pegaspargase
 
C14H19NO
 
436058 
Moderate    Inter Info   
[108], [47], [109], [48], [10], [110], [111], [112], [113], [114], [115], [49], [116]
D0113
 
Asparaginase Erwinia chrysanthemi
 
NA
 
NA
Moderate    Inter Info   
[108], [47], [109], [48], [10], [110], [111], [112], [113], [114], [115], [49], [116]
D0149
 
Bedaquiline
 
C32H31BrN2O2
 
5388906 
Moderate    Inter Info   
[122]
D0199
 
Brentuximab vedotin
 
NA
 
NA
Moderate    Inter Info   
[123]
D0232
 
Calaspargase pegol
 
NA
 
NA
Moderate    Inter Info   
[108], [47], [109], [48], [10], [110], [111], [112], [113], [114], [115], [49], [116]
D0248
 
Cannabidiol
 
C21H30O2
 
644019 
Moderate    Inter Info   
[10], [124]
D0789
 
Idelalisib
 
C22H18FN7O
 
11625818 
Moderate    Inter Info   
[141]
D1106
 
Naltrexone
 
C20H23NO4
 
5360515 
Moderate    Inter Info   
[148]
D1239
 
Peginterferon beta-1a
 
NA
 
NA
Moderate    Inter Info   
[92], [93], [94], [95]
D1389
 
Remdesivir
 
C27H35N6O8P
 
121304016 
Moderate    Inter Info   
[48], [10], [150], [151], [152]
D1615
 
Trabectedin
 
C39H43N3O11S
 
108150 
Moderate    Inter Info   
[10], [153]
   Increased risk of hypoglycemia Drug Num:  13
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1015
 
Metformin
 
C4H11N5
 
4091 
Moderate    Inter Info   
[99], [100], [101]
D1064
 
Miglitol
 
C8H17NO5
 
441314 
Moderate    Inter Info   
[99], [100], [101]
D1652
 
Troglitazone
 
C24H27NO5S
 
5591 
Moderate    Inter Info   
[99], [100], [101]
D0029
 
Albiglutide
 
C148H224N40O45
 
145994868 
Moderate    Inter Info   
[99], [100], [101]
D0042
 
Alogliptin
 
C18H21N5O2
 
11450633 
Moderate    Inter Info   
[99], [100], [101]
D0245
 
Canagliflozin
 
C24H25FO5S
 
24812758 
Moderate    Inter Info   
[99], [100], [101]
D0418
 
Dapagliflozin
 
C21H25ClO6
 
9887712 
Moderate    Inter Info   
[99], [100], [101]
D0930
 
Linagliptin
 
C25H28N8O2
 
10096344 
Moderate    Inter Info   
[99], [100], [101]
D0936
 
Liraglutide
 
C172H265N43O51
 
16134956 
Moderate    Inter Info   
[99], [100], [101]
D1294
 
Pioglitazone
 
C19H20N2O3S
 
4829 
Moderate    Inter Info   
[99], [100], [101]
D1326
 
Pramlintide
 
C171H267N51O53S2
 
70691388 
Moderate    Inter Info   
[99], [100], [101]
D1449
 
Saxagliptin
 
C18H25N3O2
 
11243969 
Moderate    Inter Info   
[99], [100], [101]
D1477
 
Sitagliptin
 
C16H15F6N5O
 
4369359 
Moderate    Inter Info   
[99], [100], [101]
   Increased risk of lowers seizure threshold Drug Num:  8
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1616
 
Tramadol
 
C16H25NO2
 
33741 
Major    Inter Info   
[15], [16], [17], [18]
D0220
 
Bupropion
 
C13H18ClNO
 
444 
Major    Inter Info   
[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [17], [16], [33]
D0833
 
Iohexol
 
C19H26I3N3O9
 
3730 
Major    Inter Info   
[34], [35], [36], [37], [38]
D0678
 
Fluphenazine
 
C22H26F3N3OS
 
3372 
Moderate    Inter Info   
[48], [10]
D0932
 
Lindane
 
C6H6Cl6
 
727 
Moderate    Inter Info   
[96], [97], [98]
D0054
 
Amifampridine
 
C5H7N3
 
5918 
Moderate    Inter Info   
[118], [119]
D0722
 
Ginkgo biloba
 
NA
 
NA
Moderate    Inter Info   
[133], [134], [135], [136], [137], [138], [139], [140]
D1308
 
Polyethylene glycol (3350 with electrolytes)
 
C2H6O2
 
174 
Moderate    Inter Info   
[69], [149], [10]
   Increased risk of photosensitivity reactions Drug Num:  5
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0062
 
Aminolevulinic acid
 
C5H9NO3
 
137 
Major    Inter Info   
[19], [20]
D1028
 
Methoxsalen
 
C12H8O4
 
4114 
Moderate    Inter Info   
[48], [105], [19], [106], [107]
D0063
 
Aminolevulinic acid (topical)
 
C5H9NO3
 
137 
Moderate    Inter Info   
[48], [10], [120]
D1033
 
Methyl aminolevulinate (topical)
 
C6H11NO3
 
157922 
Moderate    Inter Info   
[48], [10], [120]
D1691
 
Verteporfin
 
C82H84N8O16
 
11980904 
Moderate    Inter Info   
[10], [105], [19], [154]
   Increased risk of tendinitis/tendon rupture Drug Num:  8
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0172
 
Betamethasone
 
C22H29FO5
 
9782 
Major    Inter Info   
[4], [5], [6], [7], [2], [8], [9]
D1334
 
Prednisone
 
C21H26O5
 
5865 
Major    Inter Info   
[4], [5], [6], [7], [2], [8], [9]
D1628
 
Triamcinolone
 
C21H27FO6
 
31307 
Major    Inter Info   
[4], [5], [6], [7], [2], [8], [9]
D0453
 
Dexamethasone
 
C22H29FO5
 
5743 
Major    Inter Info   
[4], [5], [6], [7], [2], [8], [9]
D0671
 
Fludrocortisone
 
C21H29FO5
 
31378 
Major    Inter Info   
[4], [5], [6], [7], [2], [8], [9]
D0773
 
Hydrocortisone
 
C21H30O5
 
5754 
Major    Inter Info   
[4], [5], [6], [7], [2], [8], [9]
D1041
 
Methylprednisolone
 
C22H30O5
 
6741 
Major    Inter Info   
[4], [5], [6], [7], [2], [8], [9]
D1332
 
Prednisolone
 
C21H28O5
 
5755 
Major    Inter Info   
[4], [5], [6], [7], [2], [8], [9]
   Increased risk of other adverse reactions (Unspecific) Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0178
 
Bexarotene
 
C24H28O2
 
82146 
Major    Inter Info   
[10], [11]
      Pharmacodynamic antagonistic effects
   Antagonize the effect of antidiabetic agents Drug Num:  23
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0013
 
Acetohexamide
 
C15H20N2O4S
 
1989 
Major    Inter Info   
[1], [2], [3]
D0325
 
Chlorpropamide
 
C10H13ClN2O3S
 
2727 
Major    Inter Info   
[1], [2], [3]
D0727
 
Glimepiride
 
C24H34N4O5S
 
3476 
Major    Inter Info   
[1], [2], [3]
D0811
 
Insulin glargine
 
C267H404N72O78S6
 
118984454 
Major    Inter Info   
[1], [2], [3]
D0813
 
Insulin human
 
C257H383N65O77S6
 
118984375 
Major    Inter Info   
[1], [2], [3]
D0814
 
Insulin human (inhalation, rapid acting)
 
C257H383N65O77S6
 
118984375 
Major    Inter Info   
[1], [2], [3]
D0815
 
Insulin human (isophane)
 
C257H383N65O77S6
 
118984375 
Major    Inter Info   
[1], [2], [3]
D0816
 
Insulin human (regular)
 
C257H383N65O77S6
 
118984375 
Major    Inter Info   
[1], [2], [3]
D0817
 
Insulin human (zinc extended)
 
C257H383N65O77S6
 
118984375 
Major    Inter Info   
[1], [2], [3]
D0818
 
Insulin human (zinc)
 
C257H383N65O77S6
 
118984375 
Major    Inter Info   
[1], [2], [3]
D0819
 
Insulin lispro
 
C257H389N65O77S6
 
16132438 
Major    Inter Info   
[1], [2], [3]
D0820
 
Insulin lispro (protamine)
 
C257H389N65O77S6
 
16132438 
Major    Inter Info   
[1], [2], [3]
D0728
 
Glipizide
 
C21H27N5O4S
 
3478 
Major    Inter Info   
[1], [2], [3]
D0730
 
Glyburide
 
C23H28ClN3O5S
 
3488 
Major    Inter Info   
[1], [2], [3]
D0807
 
Insulin aspart (aspart protamine)
 
C256H381N65O79S6
 
118984445 
Major    Inter Info   
[1], [2], [3]
D0808
 
Insulin aspart (aspart)
 
C256H381N65O79S6
 
118984445 
Major    Inter Info   
[1], [2], [3]
D0809
 
Insulin degludec
 
C274H411N65O81S6
 
118984462 
Major    Inter Info   
[1], [2], [3]
D0810
 
Insulin detemir
 
C267H402N64O76S6
 
16137271 
Major    Inter Info   
[1], [2], [3]
D0812
 
Insulin glulisine
 
C258H384N64O78S6
 
16136701 
Major    Inter Info   
[1], [2], [3]
D1112
 
Nateglinide
 
C19H27NO3
 
5311309 
Major    Inter Info   
[1], [2], [3]
D1392
 
Repaglinide
 
C27H36N2O4
 
65981 
Major    Inter Info   
[1], [2], [3]
D1601
 
Tolazamide
 
C14H21N3O3S
 
5503 
Major    Inter Info   
[1], [2], [3]
D1603
 
Tolbutamide
 
C12H18N2O3S
 
5505 
Major    Inter Info   
[1], [2], [3]
   Antagonize the effect of antihypertensive agents Drug Num:  4
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1779
 
Dulaglutide
 
NA
 
NA
Moderate    Inter Info   
[99], [100], [101]
D1782
 
Ertugliflozin
 
C22H25ClO7
 
44814423 
Moderate    Inter Info   
[99], [100], [101]
D1784
 
Exenatide
 
C184H282N50O60S
 
45588096 
Moderate    Inter Info   
[99], [100], [101]
D1887
 
Semaglutide
 
C187H291N45O59
 
56843331 
Moderate    Inter Info   
[99], [100], [101]
   Antagonize the effect of vaccine/toxoid Drug Num:  2
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1914
 
Typhoid vaccine (live)
 
NA
 
NA
Major    Inter Info   
[10], [44], [45]
D1693
 
Vibrio cholerae CVD 103-HgR strain live antigen (live)
 
NA
 
NA
Major    Inter Info   
[46]
   Attenuated pharmacological effects (Unspecific) Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0145
 
Balsalazide
 
C17H15N3O6
 
54585 
Moderate    Inter Info   
[121]
References
1 Park-Wyllie LY, Juurlink DN, Kopp A, et al. "Outpatient gatifloxacin therapy and dysglycemia in older adults." N Engl J Med 354 (2006): 1352-61. [PMID: 16510739]
2 Product Information. Cipro (ciprofloxacin). Bayer, West Haven, CT.
3 Saraya A, Yokokura M, Gonoi T, Seino S "Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K(+) channels." Eur J Pharmacol 497 (2004): 111-7. [PMID: 15321742]
4 FDA. U.S. Food and Drug Administration "Information for Healthcare Professionals. Fluoroquinolone Antimicrobial Drugs. FDA Alert [7/8/2008].".
5 Khaliq Y, Zhanel GG "Fluoroquinolone-Associated Tendinopathy: A Critical Review of the Literature." Clin Infect Dis 36 (2003): 1404-1410. [PMID: 12766835]
6 Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
7 Product Information. Baxdela (delafloxacin). Melinta Therapeutics, Lincolnshire, IL.
8 Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
9 van der Linden PD, Sturkenboom MC, Herings RM, Leufkens HM, Rowlands S, Stricker BH "Increased risk of achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids." Arch Intern Med 163 (2003): 1801-7. [PMID: 12912715]
10 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
11 Product Information. Targretin (bexarotene) Ligand Pharmaceuticals, San Diego, CA.
12 Arnold LM, Nissen LR, Ng TM "Moxifloxacin and warfarin: additional evidence for a clinically relevant interaction." Pharmacotherapy 25 (2005): 904-7.[PMID: 15927911]
13 Glasheen JJ, Fugit RV, Prochazka AV "Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy--a comment." Pharmacotherapy 23 (2003): 1079-80 discussion 1080.[PMID: 12921255]
14 Bianco TM, Bussey HI, Farnett LE, Linn WD, Roush MK, Wong YW "Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation." Pharmacotherapy 12 (1992): 435-9.[PMID: 1492006]
15 Product Information. Ultram (tramadol). McNeil Pharmaceutical, Raritan, NJ.
16 Pisani F, Spina E, Oteri G "Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice." Epilepsia 40(Suppl 10) (1999): S48-56. [PMID: 10609604]
17 Rosenstein DL, Nelson JC, Jacobs SC "Seizures associated with antidepressants: a review." J Clin Psychiatry 54 (1993): 289-99. [PMID: 8253696]
18 Gardiner JS, Blough D, Drinkard CR, et al. "Tramadol and seizures: a surveillance study in a managed care population." Pharmacotherapy 20 (2000): 1423-31. [PMID: 11130214]
19 Product Information. Nulibry (fosdenopterin). Origin Biosciences Inc, Boston, MA.
20 Product Information. Gleolan (aminolevulinic acid). NX Development Corp, Lexington, KY.
21 Product Information. Wellbutrin XL (buPROPion). GlaxoSmithKline, Philadelphia, PA.
22 Sheehan DV, Welch JB, Fishman SM "A case of bupropion-induced seizure." J Nerv Ment Dis 174 (1986): 496-8. [PMID: 3090199]
23 Canadian Pharmacists Association.
24 Product Information. Wellbutrin (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
25 Gittelman DK, Kirby MG "A seizure following bupropion overdose." J Clin Psychiatry 54 (1993): 162. [PMID: 8486598]
26 Product Information. Wellbutrin SR (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
27 James WA, Lippmann S "Bupropion: overview and prescribing guidelines in depression." South Med J 84 (1991): 222-4. [PMID: 1899294]
28 Masco HL, Kiev A, Holloman LC, Batey SR, Johnston JA, Lineberry CG "Safety and efficacy of bupropion and nortriptyline in outpatients with depression." Curr Ther Res Clin Exp 55 (1994): 851-63.
29 Dufresne RL, Weber SS, Becker RE "Bupropion hydrochloride." Drug Intell Clin Pharm 18 (1984): 957-64. [PMID: 6439541]
30 Product Information. Zyban (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
31 Storrow AB "Bupropion overdose and seizure." Am J Emerg Med 12 (1994): 183-4. [PMID: 8161393]
32 Johnston JA, Lineberry CG, Ascher JA, et al. "A 102-center prospective study of seizure in association with bupropion." J Clin Psychiatry 52 (1991): 450-6. [PMID: 1744061]
33 Product Information. Aplenzin (buPROPion). sanofi-aventis , Bridgewater, NJ.
34 Product Information. Isovue-M-200 (iopamidol). Bracco Diagnostics Inc, Princeton, NJ.
35 Product Information. Amipaque (metrizamide) Nycomed Inc, Princeton, NJ.
36 Hindmarsh T, Grepe A, Widen L "Metrizamide-phenothiazine interaction: report of a case with seizures following myelography." Acta Radiol Diagn (Stockh) 16 (1975): 129-35. [PMID: 810000]
37 Product Information. Omnipaque 180 (iohexol). Amersham Health, Princeton, NJ.
38 Product Information. Osmovist 240 (iotrolan). Berlex Canada Inc, Lachine, QC.
39 EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
40 Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
41 Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
42 Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
43 Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
44 UK government "Typhoid.".
45 American Medical Association, Division of Drugs and Toxicology "Drug evaluations annual 1994." Chicago, IL: American Medical Association (1994).
46 Product Information. Vaxchora (cholera vaccine, live). PaxVax, Miami, FL.
47 Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
48 Cerner Multum, Inc. "Australian Product Information.".
49 Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
50 Akerele JO, Okhamafe AO "Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics." J Antimicrob Chemother 28 (1991): 87-94. [PMID: 1663108]
51 Allen A, Vousden M, Porter A, Lewis A "Effect of Maalox((R)) on the bioavailability of oral gemifloxacin in healthy volunteers." Chemotherapy 45 (1999): 504-11. [PMID: 10567782]
52 Campbell NR, Kara M, Hasinoff BB, Haddara WM, McKay DW "Norfloxacin interaction with antacids and minerals." Br J Clin Pharmacol 33 (1992): 115-6. [PMID: 1540482]
53 Frost RW, Lasseter KC, Noe AJ, Shamblen EC, Lettieri JT "Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin." Antimicrob Agents Chemother 36 (1992): 830-2. [PMID: 1503446]
54 Garrelts JC, Godley PJ, Peterie JD, Gerlach EH, Yakshe CC "Sucralfate significantly reduces ciprofloxacin concentrations in serum." Antimicrob Agents Chemother 34 (1990): 931-3. [PMID: 2360833]
55 Grasela TH Jr, Schentag JJ, Sedman AJ, et al "Inhibition of enoxacin absorption by antacids or ranitidine." Antimicrob Agents Chemother 33 (1989): 615-7. [PMID: 2751276]
56 Honig PK, Gillespie BK "Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs." Clin Pharmacokinet 35 (1998): 167-71. [PMID: 9784931]
57 Johnson RD, Dorr MB, Talbot GH, Caille G "Effect of Maalox on the oral absorption of sparfloxacin." Clin Ther 20 (1998): 1149-58. [PMID: 9916608]
58 Kamberi M, Nakashima H, Ogawa K, Oda N, Nakano S "The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin." Br J Clin Pharmacol 49 (2000): 98-103. [PMID: 10671902]
59 Lehto P, Kivisto KT "Different effects of products containing metal ions on the absorption of lomefloxacin." Clin Pharmacol Ther 56 (1994): 477-82. [PMID: 7955811]
60 Lehto P, Kivisto KT "Effect of sucralfate on absorption of norfloxacin and ofloxacin." Antimicrob Agents Chemother 38 (1994): 248-51. [PMID: 8192452]
61 Lober S, Ziege S, Rau M, Schreiber G, Mignot A, Koeppe P, Lode H "Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium." Antimicrob Agents Chemother 43 (1999): 1067-71. [PMID: 10223915]
62 Nix DE, Watson WA, Lener ME, et al "Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin." Clin Pharmacol Ther 46 (1989): 700-5. [PMID: 2598571]
63 Nix DE, Wilton JH, Ronald B, Distlerath L, Williams VC, Norman A "Inhibition of norfloxacin absorption by antacids." Antimicrob Agents Chemother 34 (1990): 432-5. [PMID: 2334155]
64 Noyes M, Polk RE "Norfloxacin and absorption of magnesium-aluminum." Ann Intern Med 109 (1988): 168-9. [PMID: 3382110]
65 Parpia SH, Nix DE, Hejmanowski LG, Goldstein HR, Wilton JH, Schentag JJ "Sucralfate reduces the gastrointestinal absorption of norfloxacin." Antimicrob Agents Chemother 33 (1989): 99-102. [PMID: 2712548]
66 Polk RE, Helay DP, Sahai J, Drwal L, Racht E "Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers." Antimicrob Agents Chemother 33 (1989): 1841-4. [PMID: 2610494]
67 Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
68 Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
69 Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
70 Product Information. Trovan (trovafloxacin). Pfizer US Pharmaceuticals, New York, NY.
71 Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
72 Sahai J, Healy DP, Stotka J, Polk RE "The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin." Br J Clin Pharmacol 35 (1993): 302-4. [PMID: 8471407]
73 Shimada J, Shiba K, Oguma T, et al "Effect of antacid on absorption of the quinolone lomefloxacin." Antimicrob Agents Chemother 36 (1992): 1219-24. [PMID: 1329615]
74 Spivey JM, Cummings DM, Pierson NR "Failure of prostatitis treatment secondary to probable ciprofloxacin-sucralfate drug interaction." Pharmacotherapy 16 (1996): 314-6. [PMID: 8820479]
75 Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J "Effect of Maalox and omeprazole on the bioavailability of trovafloxacin." J Antimicrob Chemother 39 Suppl B (1997): 93-7. [PMID: 9222077]
76 Wadworth AN, Goa KL "Lomefloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use." Drugs 42 (1991): 1018-60. [PMID: 1724637]
77 Yuk JH "Ciprofloxacin levels when receiving sucralfate." J Am Geriatr Soc 262 (1989): 901. [PMID: 2754785]
78 Zix JA, Geerdes-Fenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
79 Deppermann KM, Lode H, Hoffken G, Tschink G, Kalz C, Koeppe P "Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid." Antimicrob Agents Chemother 33 (1989): 1901-7. [PMID: 2610502]
80 Product Information. Floxin (ofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
81 Product Information. Penetrex (enoxacin). Rhone-Poulenc Rorer, Collegeville, PA.
82 Davey PG "Overview of drug interactions with the quinolones." J Antimicrob Chemother 22(suppl c) (1988): 97-107. [PMID: 3053579]
83 Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
84 Ball P, Tillotson G "Tolerability of fluoroquinolone antibiotics: past, present and future." Drug Saf 13 (1996): 343-8. [PMID: 8652079]
85 Segev S. Rehavi M, Rubinstein E "Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor." Antimicrob Agents Chemother 32 (1988): 1624-6. [PMID: 2855295]
86 Domagala JM "Structure-activity and structure-side-effect relationships for the quinolone antibacterials." J Antimicrob Chemother 33 (1994): 685-706. [PMID: 8056688]
87 Hooper DC, Wolfson JS "The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans." Antimicrob Agents Chemother 28 (1985): 716-21. [PMID: 2936302]
88 Ball P "Ciprofloxacin: an overview of adverse experiences." J Antimicrob Chemother 18 (1986): 187-93. [PMID: 3542945]
89 Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
90 Elsharkawy AM, Schwab U, McCarron B, et al. "Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser." J Clin Virol 58 (2013): 331-3. [PMID: 23763943]
91 Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
92 Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
93 Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
94 Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
95 Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
96 Matsuoka LY "Convulsions following application of gamma benzene hexachloride." J Am Acad Dermatol 5 (1981): 98-9. [PMID: 6168673]
97 Cox R, Krupnick J, Bush N, Houpt A "Seizures caused by concomitant use of lindane and dextroamphetamine in a child with attention deficit hyperactivity disorder." J Miss State Med Assoc 41 (2000): 690-2. [PMID: 10974795]
98 Product Information. Kwell (lindane). Reed and Carnrick, Jersey City, NJ.
99 Gavin JR 3rd, Kubin R, Choudhri S, et al "Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies." Drug Saf 27 (2004): 671-86. [PMID: 15230648]
100 Kelesidis T, Canseco E "Quinolone-induced hypoglycemia: a life-threatening but potentially reversible side effect." Am J Med 123 (2010): e5-6. [PMID: 20103009]
101 Yip C, Lee AJ "Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature." Clin Ther 28 (2006): 1857-66. [PMID: 17213006]
102 Johnson EJ, MacGowan AP, Potter MN, et al "Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy." J Antimicrob Chemother 25 (1990): 837-42. [PMID: 2373666]
103 Nesher G, Mates M, Zevin S "Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis." Arthritis Rheum 48 (2003): 571-572. [PMID: 12571869]
104 Dalle JH, Auvrignon A, Vassal G, Leverger G "Interaction Between Methotrexate and Ciprofloxacin." J Pediatr Hematol Oncol 24 (2002): 321-322
105 Multum Information Services, Inc. Expert Review Panel.
106 Product Information. Oxsoralen (methoxsalen). ICN Pharmaceuticals Inc, Costa Mesa, CA.
107 Product Information. Uvadex (methoxsalen). Therakos Inc, Exton, PA.
108 Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
109 Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
110 Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
111 Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
112 Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
113 Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
114 Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
115 Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
116 Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
117 Kays MB, Overholser BR, Mueller BA, Moe SM, Sowinski KM "Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin." Am J Kidney Dis 42 (2003): 1253-9. [PMID: 14655198]
118 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
119 Product Information. Firdapse (amifampridine). Catalyst Pharmaceuticals, Inc., Coral Gables, FL.
120 Product Information. Metvixia (methyl aminolevulinate topical). Galderma Laboratories Inc, Cranbury, NJ.
121 Product Information. Colazal (balsalazide) Salix Pharmaceuticals, Palo Alto, CA.
122 Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
123 Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
124 Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
125 Knupp CA, Barbhaiya RH "A multiple-dose pharmacokinetic interaction study between didanosine (videx(r)) and ciprofloxacin (cipro(r)) in male subjects seropositive for HIV but asymptomatic." Biopharm Drug Dispos 18 (1997): 65-77. [PMID: 9008270]
126 Marchbanks CR "Drug-drug interactions with fluoroquinolones." Pharmacotherapy 13 (1993): s23-8. [PMID: 8474934]
127 Polk RE "Drug-drug interactions with ciprofloxacin and other fluoroquinolones." Am J Med 87 (1989): s76-81. [PMID: 2686430]
128 Sahai J, Gallicano K, Oliveras L, Khaliq S, Hawley-Foss N, Garber G "Cations in the didanosine tablet reduce ciprofloxacin bioavailability." Clin Pharmacol Ther 53 (1993): 292-7. [PMID: 8453847]
129 Damle BD, Mummaneni V, Kaul S, Knupp C "Lack of Effect of Simultaneously Administered Didanosine Encapsulated Enteric Bead Formulation (Videx EC) on Oral Absorption of Indinavir, Ketoconazole, or Ciprofloxacin." Antimicrob Agents Chemother 46 (2002): 385-91. [PMID: 11796346]
130 Friedman CI, Huneke AL, Kim MH, Powell J "The effect of ampicillin on oral contraceptive effectiveness." Obstet Gynecol 55 (1980): 33-7. [PMID: 7188714]
131 Kleier DJ, Tucker JE "Oral contraceptive failure secondary to dentally prescribed drugs: fact or fiction?" J Colo Dent Assoc 66 (1987): 5-6. [PMID: 3478352]
132 Silber TJ "Apparent oral contraceptive failure associated with antibiotic administration." J Adolesc Health Care 4 (1983): 287-9. [PMID: 6643209]
133 Kajiyama Y, Fujii K, Takeuchi H, Manabe Y "Ginkgo seed poisoning." Pediatrics 109 (2002): 325-7. [PMID: 11826216]
134 Granger AS "Ginkgo biloba precipitating epileptic seizures." Age Ageing 30 (2001): 523-5. [PMID: 11742783]
135 Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11. [PMID: 9818800]
136 Spinella M "Herbal medicines and epilepsy: the potential for benefit and adverse effects." Epilepsy Behav 2 (2001): 524-32. [PMID: 12609386]
137 Gregory PJ "Seizure associated with Ginkgo biloba?." Ann Intern Med 134 (2001): 344. [PMID: 11182853]
138 Harms SL, Garrard J, Schwinghammer P, Eberly LE, Chang Y, Leppik IE "Ginkgo biloba use in nursing home elderly with epilepsy or seizure disorder." Epilepsia 47 (2006): 323-9. [PMID: 16499756]
139 Miwa H, Iijima M, Tanaka S, Mizuno Y "Generalized convulsions after consuming a large amount of Gingko nuts." Epilepsia 42 (2001): 280-1. [PMID: 11240603]
140 Kupiec T, Raj V "Fatal seizures due to potential herb-drug interactions with Ginkgo biloba." J Anal Toxicol 29 (2005): 755-8. [PMID: 16419414]
141 Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
142 Product Information. Indium Oxyquinoline In-111 (indium oxyquinoline In-111). GE Healthcare, Princeton, NJ.
143 Product Information. Fosrenol (lanthanum carbonate). Shire US Inc, Florence, KY.
144 Product Information. Nuzyra (omadacycline). Paratek Pharmaceuticals, Inc., Boston, MA.
145 Product Information. Seysara (sarecycline). Allergan Inc, Irvine, CA.
146 Product Information. CellCept (mycophenolate mofetil). Roche Laboratories, Nutley, NJ.
147 Product Information. Myfortic (mycophenolic acid). Novartis Pharmaceuticals, East Hanover, NJ.
148 Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
149 Salik JM, Kurtin P "Severe hyponatremia after colonoscopy preparation in a patient with the acquired immune deficiency syndrome." Am J Gastroenterol 80 (1985): 177-9. [PMID: 2983533]
150 European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
151 Gilead Sciences, Inc "About Remdesivir.".
152 US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
153 Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
154 Product Information. Visudyne (verteporfin) Valeant Pharmaceuticals, Costa Mesa, CA.
155 Weidekamm E, Portmann R, Suter K, et al "Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans." Antimicrob Agents Chemother 31 (1987): 1909-14
156 Shimada J, Yamaji T, Ueda Y, Uchida H, Kusajma H, Irikura T "Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans." Antimicrob Agents Chemother 23 (1983): 1-7